Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 13, 2016 2:28 AM ET

Capital Markets

Company Overview of Novartis Venture Fund

Company Overview

Novartis Venture Fund is an evergreen fund. It is stage agnostic, engaging in investment from seed-to-growth capital-to-later stage including mezzanine financings. It can also invest in other stages. It focuses on Series A and B for initial investment. The fund prefers to invest in product-and platform-focused biotech, pharmaceutical, and healthcare sectors. It seeks to make equity investments in life sciences companies across biotechnology/biopharma, medical devices, and diagnostics. The fund has primary investment focus on the development of novel therapeutics and platforms. It also looks broadly to invest in all types of healthcare innovation. The fund primarily invests globally primarily...

Postfach

Basel,  4002

Switzerland

Founded in 1996

Phone:

41 61 324 32 67

Fax:

41 61 324 86 79

Key Executives for Novartis Venture Fund

President
Age: 59
Managing Director
Age: 38
Managing Director
Age: 51
Managing Director
Compensation as of Fiscal Year 2015.

Novartis Venture Fund Key Developments

Novartis Venture Fund Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-29-2015 11:20 AM

Novartis Venture Fund Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-29-2015 11:20 AM. Venue: Congress Center, Basel, Switzerland. Speakers: Markus Goebel, Partner.

Novartis Venture Fund Presents at Bio-Trinity, May-11-2015

Novartis Venture Fund Presents at Bio-Trinity, May-11-2015 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.

Novartis Venture Fund Presents at The 15th annual New York Venture Summit 2015, Jun-24-2015

Novartis Venture Fund Presents at The 15th annual New York Venture Summit 2015, Jun-24-2015 . Venue: The Digital Sandbox, 55 Broad Street 4th Floor, New York, NY 10004, United States. Speakers: Christine Brennan, Principal.

Similar Private Companies By Industry

Company Name Region
2thePoint AG Europe
Generation Alfa SA, Investment Banking Arm Europe
Ural Invest S.A. Europe
Pke Pensionskasse Energie Europe
IFIT Fund Services AG Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 11, 2015
eFFECTOR Therapeutics, Inc.
Private Placement
October 1, 2015
Galera Therapeutics, Inc.
Private Placement
September 1, 2015
Proteostasis Therapeutics, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Novartis Venture Fund, please visit www.nvfund.com/. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.